Evaluation of hypolipidemic effect of Pueraria tuberosa extract on high-fat diet induced hyperlipidemia in Wistar rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20260432Keywords:
Dyslipidemias, Low-density lipoproteins, HMG COA reductase inhibitors, Cholesterol, Plant extractAbstract
Background: Low-density lipoproteins (LDL)-C plays a pivotal role in the development of atherosclerosis, and its reduction is a primary target in the management of dyslipidemia. Pueraria tuberosa contains Puerarin, increases LDL receptor (LDLr) mRNA and HMG-CoA reductase mRNA invitro. However, its role as an hypolipidemic agents needs further elucidation.
Methods: IAEC permission was sought (IAEC/GSMC/05/2022). Wistar rats of either sex around 150-200 grams were divided into 5 groups (n= 8). Group NC (Normal control) received a normal chow diet while Group DC (disease control), Group PC (Atorvastatin 10mg/kg/day), Group PTE LD (PTE 500mg/kg/day) and Group PTE HD (PTE 1000mg/kg/day) received high-fat diet for 45 days. Atorvastatin and Pueraria tuberosa aqueous extract (PTE) were given from the 15th day to the 45th day to the respective groups. Lipid profile, and HMG COA reductase enzyme levels were analysed and compared between groups using one-way ANOVA and Kruskal-Wallis test followed by post hoc analysis (p<0.05).
Results: PTE HD significantly decreased total cholesterol and LDL-C, compared to the disease control group. Conclusions: According to our findings, Pueraria tuberosa aqueous extract exert a hypolipdemic effect at higher doses as evidenced by decrease in total cholesterol and LDL-C.
Metrics
References
Dybiec J, Baran W, Dąbek B, Fularski P, Młynarska E, Radzioch E, et al. Advances in Treatment of Dyslipidemia. IJMS. 2023;24(17):13288. DOI: https://doi.org/10.3390/ijms241713288
VizHub - GBD Results. Available at: https://vizhub.healthdata.org/gbd-results/. Accessed on 17 November 2025.
Puri R, Mehta V, Duell PB, Nair D, Mohan JC, Yusuf J, et al. Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India. Journal of Clinical Lipidology. 2020;14(2):e1-13. DOI: https://doi.org/10.1016/j.jacl.2020.01.006
Prabhakaran D, Jeemon P, Roy A. Cardiovascular Diseases in India: Current Epidemiology and Future Directions. Circulation. 2016;133(16):1605-20. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.008729
Munshi R, Joshi S, Rane B. Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance, markers for coronary heart disease. Indian J Pharmacol. 2014;46(3):270-6. DOI: https://doi.org/10.4103/0253-7613.132156
Mehta V, Puri R, Duell PB, Iyengar SS, Wong ND, Yusuf J, et al. Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic Acid. JAPI. 2022;70(9):11-12. DOI: https://doi.org/10.5005/japi-11001-0099
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. ATVB. 2019 ;39(2):e38-81. DOI: https://doi.org/10.1161/ATV.0000000000000081
Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, et al. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II. Atherosclerosis. 2017;266:158-66. DOI: https://doi.org/10.1016/j.atherosclerosis.2017.08.013
McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, et al. Factors Related to Adherence to Statin Therapy. Ann Pharmacother. 2007 ;41(11):1805-11. DOI: https://doi.org/10.1345/aph.1K209
Rouhi-Boroujeni H, Rouhi-Boroujeni H, Heidarian E, Mohammadizadeh F, Rafieian-Kopaei M. Herbs with anti-lipid effects and their interactions with statins as a chemical anti- hyperlipidemia group drugs: A systematic review. ARYA Atheroscler. 2015;11(4):244-51.
Rampilla V, Mahammad K. Ethno-Medicinal Plants in Sacred Groves in East Godavari District, Andhra Pradesh, India. EJMP. 2015;9(4):1-29. DOI: https://doi.org/10.9734/EJMP/2015/18802
Keung WM. 2002. Available at: https://www.taylorfrancis.com/books/9780203300978. Accessed on 17 November 2025.
Shukla R, Banerjee S, Tripathi YB. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats. BMC Complement Altern Med. 2018;18(1):156. DOI: https://doi.org/10.1186/s12906-018-2221-x
Chung MJ, Sung NJ, Park CS, Kweon DK, Mantovani A, Moon TW, et al. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. Eur J Pharmacol. 2008;578(3):159-70. DOI: https://doi.org/10.1016/j.ejphar.2007.09.036
Bharti R, Chopra BS, Raut S, Khatri N. Pueraria tuberosa: A Review on Traditional Uses, Pharmacology, and Phytochemistry. Front Pharmacol. 2021;11:582506. DOI: https://doi.org/10.3389/fphar.2020.582506
Venkadeswaran K, Thomas PA, Geraldine P. An experimental evaluation of the anti-atherogenic potential of the plant, Piper betle , and its active constitutent, eugenol, in rats fed an atherogenic diet. Biomed Pharmacother. 2016;80:276-88. DOI: https://doi.org/10.1016/j.biopha.2016.03.028
Yurina V, Yunita E, Raras T, Rudijanto A, Handono K. Prolonged-heated High-Fat Diet Increase the Serum LDL Cholesterol Level and Induce the Early Atherosclerotic Plaque Development in Wistar Rats. JTLS. 2019;9(1):9-14. DOI: https://doi.org/10.11594/jtls.09.01.02
Singh DK, Kumar N, Sachan A, Lakhani P, Tutu S, Nath R, et al. Hypolipidaemic Effects of Gymnema sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar Rats. J Clin of Diagn Res. 2017;11(5):FF01-5. DOI: https://doi.org/10.7860/JCDR/2017/27430.9859
Agnello F, Ingala S, Laterra G, Scalia L, Barbanti M. Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management. JCM. 2024;13(5):1251. DOI: https://doi.org/10.3390/jcm13051251
Islam SU, Ahmed MB, Ahsan H, Lee YS. Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease. Antioxidants. 2021;10(5):784. DOI: https://doi.org/10.3390/antiox10050784
Aditi P, Tripathi YB. Antioxidative and hypolipidemic effect of pueraria tuberosa water extract (PTWE) in rats with high fat diet induced non-alcoholic fatty liver disease (NAFLD). Int J Pharm Sci Res. 2010;48(3):220-5.
Satpathy S, Patra A, Hussain MD, Kazi M, Aldughaim MS, Ahirwar B. A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells. PLoS ONE. 2021;16(1):e0240068. DOI: https://doi.org/10.1371/journal.pone.0240068
Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Kawanaka K, et al. Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. Am J Physiol. 1997;273(1):E37-45. DOI: https://doi.org/10.1152/ajpendo.1997.273.1.E37
Ble-Castillo JL, Aparicio-Trapala MA, Juárez-Rojop IE, Torres-Lopez JE, Mendez JD, Aguilar-Mariscal H, et al. Differential Effects of High-Carbohydrate and High-Fat Diet Composition on Metabolic Control and Insulin Resistance in Normal Rats. IJERPH. 2012;9(5):1663-76. DOI: https://doi.org/10.3390/ijerph9051663
Poznyak AV, Sukhorukov VN, Eremin II, Nadelyaeva II, Orekhov AN. Diagnostics of atherosclerosis: Overview of the existing methods. Front Cardiovasc Med. 2023;10:1134097. DOI: https://doi.org/10.3389/fcvm.2023.1134097
Downloads
Published
How to Cite
Issue
Section
